BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 28, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory front for Feb. 4, 2020

Feb. 4, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: GE Healthcare.
Read More

Other news to note for Feb. 4, 2020

Feb. 4, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aevi Genomics, Anika, Anteros, Athenex, Arthrosurface, Beijing CC-Pharming, Biomotiv, Biosense Webster, BMS, Boehringer, Cerecor, Contrafect, Cormedix, CNS Pharmaceuticals, Equinox, Eyepoint, FSD, Genekam, Ibio, Inprother, Levena, Mablytics, Navrogen, Pattern Bioscience, Plex, Porton Pharma, Q Biomed, Rhythm AI, Salarius, Samus, Sirion, Solarvest, Syntrix, Theratechnologies, Trefoil, Trianni.
Read More
2-3-Azar-HHS.png

HHS declares public health emergency in part because CDC test for coronavirus unreliable

Feb. 3, 2020
By Mark McCarty
The U.S. Department of Health and Human Services has declared a public health emergency in the U.S. over the coronavirus in part because a government diagnostic for the virus yields inconsistent results, a fact that may spur the life sciences to provide a solution.
Read More
2-3-Novacyt-primerdesign-genesig-16.png

Novacyt launches test for new coronavirus

Feb. 3, 2020
By Meg Bryant
As the deadly coronavirus continues to spread, countries around the world are scrambling to understand the public health threat and identify and quarantine people who may be infected. To that end, Novacyt SA has launched a molecular test that detects only the 2019 strain of the coronavirus, reducing the chance of false diagnoses.
Read More
Man wearing mask, receiving coronavirus vaccine

Gilead’s remdesivir enters China phase III trial to fight coronavirus

Feb. 3, 2020
By Elise Mak
BEIJING – China will kickstart a phase III trial Feb. 3 to determine whether patients with 2019-nCoV can be treated with Gilead Sciences Inc.’s NUC inhibitor, remdesivir, which was originally developed for Ebola, four days after a U.S. patient was said to have recovered by using the drug candidate. 
Read More

Other news to note for Feb. 3, 2020

Feb. 3, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Anticancer, Applied Biomath, Artelo, Aspen Global, Astrazeneca, Avacta, Be Cool, Biomx, Cellink, Citius, Daewoong, Enochian, Gritstone, Inovio, Nektar, Novartis, Precigen, PTC Therapeutics, Sandoz.
Read More
DNA

Bench Press for Jan. 31, 2020

Jan. 31, 2020
By Anette Breindl
BioWorld looks at translational medicine, including: Adapting NGS for coronavirus surveillance; Long QT genes mostly short on evidence; Reservoir dogs don’t hunt; Another reason to get a flu shot; Cerebrospinal fluid is early culprit in stroke edema; Different drivers can turn the wheel in glioblastoma’s vicious cycle; From African genomes, big insights with small sample size; Commercial antibodies underwhelm for studies of PP2A; Tau keeps gliomas in check.
Read More
Time perception clocks

With rapid transmission of 2019-nCoV, how fast is fast enough for communication?

Jan. 31, 2020
By Anette Breindl and Elise Mak
BEIJING – The current speed of new developments in the 2019-nCov outbreak is illustrated by a Jan. 28, 2020, press conference in Munich, where Andreas Zapf, head of the infection task force in the Bavarian ministry for health and food safety, briefed reporters on the first confirmed German case.
Read More

Other news to note for Jan. 31, 2020

Jan. 31, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspen, Curevac, Follicum, Fuzionaire, ICER, Nanoviricides, Novartis, Predictive Oncology, Quantitative Medicine, Saromics, Vaxart, Ziopharm.
Read More

Other news to note for Jan. 30, 2020

Jan. 30, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcam, Applied Stemcell, Best Medical International, Bgi, Biofourmis, Conmed, Curetis, Fuzionaire Diagnostics, Healthfirst, Hollister, ImagineMIC, Microsoft, Nationshearing, Transenterix
Read More
Previous 1 2 … 530 531 532 533 534 535 536 537 538 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 27, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Dice spelling out D-E-A-L-?, yes, no

    Muted and missing M&As: JPM deals absent in 2026

    BioWorld
    For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing